David Brunton
Analyst · Cowen & Company
Thanks Thomas. I will begin by going through our results for the quarter ended September 30, 2012, and then move on to the nine month period. First, I’m going to discuss some high level growth related activities that have served to increase the company’s overall expense levels in 2012 as compared to 2011. Salaries and benefits are approximately 55% of our total expense. In 2011, we had on average approximately 20 full time employees throughout the year. That number has increased to an average of 38 employees through the first nine months of 2012 and we currently have 45 full time employees. We hire highly skilled optical, mechanical and software engineers to work with our customers in their product design efforts as well as to develop new and exciting technology and intellectual property. In the future, as our customer wins increase, we expect to continue to hire engineers to support our customer’s requirements. We also increased our marketing and IP legal budgets from virtually nothing in 2011 to approximately $600,000 in the first nine months of 2012. We have focused our efforts to produce marketing materials for our sales department and to increase our participation in industry trade shows like CES and Mobile World Congress. The development in IP protection of new innovation is one of our core values and we have increased our budget to support these efforts. And of course, our travel expense has been seeing significant growth as our customer base and global reaches increased in the first nine months of 2012 as compared to 2011. Keep these items in mind as I discuss the period-to-period comparisons since they are the primary cause of the expense increases for both the quarter and nine months just ended. Our net revenue for the third quarter of 2012 increased 30% to $1.7 million, compared to $1.3 million for the same period in 2011. Our net revenues for the quarter just ended include $1.6 million of license fees related to e-reader product shipments by five customers, Amazon, Barnes & Noble, Sony, Kobo and Netronix plus the first shipments of the MEEP! children’s tablet by Oregon Scientific. This compares to $1.2 million of license fees related to e-reader product shipments for the quarter ended September 30, 2011. In addition to license fees, we also recognized a $120,000 of customer development project related engineering fees in the quarter just ended, compared to $82,000 in the same quarter of 2011. Our cost of revenue for the third quarter of 2012 of $337,000 was relatively flat compared to the $330,000 in the third quarter of 2011. It is important to note that we do not incur any cost of revenue related to our license fees. Our license fee revenues have a 100% gross margin and as our future license fee revenue increase as a percentage of our total revenue, we anticipate that our total gross margin will increase. Our product R&D for the third quarter of 2012 increased 227% to $1.5 million, compared to $385,000 in the third quarter of 2011. As Thomas previously stated, we have seen an increase in design wins and development activities in 2012. This increase in R&D reflects an increase in staffing as I previously discussed. As of September 30, 2012, included in the R&D for the quarter just ended is $73,000 of non-cash stock option expense compared to $2000 for the same quarter in 2011. Our sales and marketing expense for the third quarter of 2012 increased 124% to $920,000, compared to $411,000 in the third quarter of 2011, again due to an increase in our staffing levels and marketing activities. Included in sales and marketing expense for the quarter just ended is $250,000 of non-cash stock option expense compared to $23,000 in the same quarter of 2011. Our G&A expense for the third quarter of 2012 increased 110% to $1.1 million, compared to $518,000 in the third quarter of 2011. Increase in our staffing levels plus we saw an increase in the overall cost related to our SEC and NASDAQ compliance and legal expense for customer contracts. Included in G&A expense for the quarter just ended is $284,000 of non-cash stock option expense, compared to $17,000 in the same quarter of 2012. Our adjusted EBITDA as defined in press release issued earlier today is a loss of $1.5 million for the third quarter ended September 30, 2012, compared to a loss of $311,000 for the same period in 2011. Please review our earnings release issued this morning where we provide a reconciliation of net loss to EBITDA. The net loss for the third quarter of 2012 was $2.1 million or $0.06 per share on 33 million shares basic and diluted compared to a loss of $1.9 million or $0.07 per share on 2.7 million basic and diluted shares of stock for the same period in 2011. I will now summarize the nine months ended September 30, 2012. Please keep in mind the comments about the trends that I made previously. Our net revenue for the first nine months of 2012 increased 128% to $4.8 million, compared to $2.1 million for the same period in 2011. Our net revenues for the nine months just ended include $4.1 million of license fee related to product shipments for the same customers previously mentioned. This compares to $1.8 million of license fees related to product shipments by e-reader customers in the same period ended September 30, 2011. The revenue for 2011 includes $475,000 of license fee related to Sony product shipped in the fourth quarter of 2010 that was previously included in deferred revenue and recognized in revenue in 2011. In addition to license fees, we also recognized $765,000 of customer development project related engineering fees in the first nine months of 2012 compared to $299,000 in the same period of 2011. The cost of revenue for the first nine months of 2012 increased 48% to $1.1 million compared to $726,000 for the same period in 2011. Last year, the design activity was centered primarily in the e-reader space. This year and currently, over 80% of the design activity is in other product markets like printers, tablets, mobile phones, and automotive devices. Product R&D for the first nine months of 2012 increased 247% to $3.6 million compared to $1 million in the third quarter of 2011. Included in R&D for the nine months of 2012 is $260,000 of non-cash stock option expense compared to $111,000 for the same period in 2011. Our sales and marketing expense for the nine months of 2012 increased 205% to $3.4 million compared to $1.1 million in the same period of 2011. Included in sales and marketing expense for the nine months just ended is $1.2 million of non-cash stock option and warrant expense compared to $70,000 in the same period in 2011. Our G&A expense for the first nine months of 2012 increased 64% to $3.8 million compared to $2.3 million in 2011. Included in G&A expense for the nine months just ended is $1.5 million of non-cash stock option expense, compared to $336,000 for the same period in 2011. Adjusted EBITDA as defined by our press release issued earlier today is a loss of $4.1 million for the nine months ended September 30, 2012, compared to a loss of $2.6 million for the same period in 2011. The net loss for the first nine months of 2012 is $7.2 million or $0.22 per share on 32.9 million basic and diluted shares of stock compared to a loss of $14.4 million or $0.55 per share on 26 million basic and diluted shares of stock outstanding for the same period in 2011. Our operations used approximately $1.6 million in cash during the first nine months of 2012. Now, I will move on to the balance sheet. As of September 30, 2012, we reported cash of approximately $11.2 million compared to $12.9 million as of December 31, 2011. In addition, we have $1.5 million of accounts receivable related to customer’s third quarter sales. As of September 30, 2012, we have working capital of $9.3 million compared to working capital of $13.6 million at December 31, 2011. Our shareholder equity stood at $9.7 million as of the September 30, 2012 compared to $13.7 million as of December 31, 2011. As of September 30, 2012, we have 33.1 million shares of common stock plus 4.9 million warrants and 1.5 million stock options outstanding for a total of 39.5 million shares of fully diluted stock. Now, I would like to turn the call back over to Thomas for some closing comments.